Author

G. J. Gutierrez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:C. elegans· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Siebers· 1 shared C. Eggermont· 1 shared D. Vertommen· 1 shared E. Peeters· 1 shared H. R. Maklad· 1 shared H. Vandenplas· 1 shared I. Bervoets· 1 shared J. De Greve· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. Siebers

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Protein kinase Sut1 from the Crenarchaeon Sulfolobus acidocaldarius displays tyrosine phosphorylation activity

H. R. Maklad, S. P. d. Ruys, I. Bervoets, D. Vertommen, G. J. Gutierrez, W. F. Vranken, B. Siebers, E. Peeters

The paper identifies and characterizes Sut1, a tyrosine kinase in Sulfolobus acidocaldarius, showing it phosphorylates tyrosine residues in vitro and belongs to a novel archaeal kinase family.

bioRxiv · Jan 14, 2024 · PreprintMicrobiology

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

C. Eggermont, P. Giron, M. Noeparast, H. Vandenplas, P. Aza-Blanc, G. J. Gutierrez, J. De Greve

This study identifies STYK1 as a target that enhances the effects of EGFR inhibition in NSCLC cells, suggesting co-targeting EGFR and STYK1 may improve treatment outcomes.

bioRxiv · Apr 26, 2022Cancer Biology